Cargando…
PHARMACEUTICAL PRICING IN EMERGING MARKETS: EFFECTS OF INCOME, COMPETITION, AND PROCUREMENT
This paper analyzes determinants of ex-manufacturer prices for originator and generic drugs across countries. We focus on drugs to treat HIV/AIDS, TB, and malaria in middle and low-income countries (MLICs), with robustness checks to other therapeutic categories and the full income range of countries...
Autores principales: | Danzon, Patricia M, Mulcahy, Andrew W, Towse, Adrian K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320771/ https://www.ncbi.nlm.nih.gov/pubmed/24293058 http://dx.doi.org/10.1002/hec.3013 |
Ejemplares similares
-
Dynamics of price competition in Italian pharmaceutical off-patent market
por: Perna, Serena, et al.
Publicado: (2022) -
Collective pharmaceutical procurement in China may have unintended consequences in supply and pricing
por: Jiang, Shan, et al.
Publicado: (2020) -
Who initiates price competition when generic entrants are introduced into the South Korean pharmaceutical market?
por: Son, Kyung-Bok
Publicado: (2022) -
Competition and efficiency in repeated procurements: Lessons from the Finnish rehabilitation markets
por: Pitkänen, Visa
Publicado: (2022) -
Pharmaceutical procurement among public sector procurers in CARICOM
por: Preston, Charles, et al.
Publicado: (2021)